title: Inhaled pentamidine for Pneumocystis jiroveci prophylaxis in a heart transplant recipient with allergy for trimethoprim sulfamethoxazole.
abstract: Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprimsulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole.
authors: Turkiye Yuksek Ihtisas Hospital, Department Of Cardiovascular Surgery, Ankara, Turkey.
authors: Garip
authors: G
authors: Altintas
authors: Adem Ilkay
authors: AI
authors: Diken
authors: Ozlem Ercen
authors: OE
authors: Diken
authors: Onur
authors: O
authors: Hanedan
authors: Seref Alp
authors: SA
authors: Kucuker